BridgeMD
New treatment option for Obesity
Official title A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
ClinicalTrials.gov ID: NCT07564414
What this study is testing
What is Cagrisema?
Cagrisema is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for obesity.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants.
- Phase 3: a large, late-stage study
- Time commitment: about 83 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female (sex assigned at birth, inclusive of all gender identities).
- Age 18 years or above at the time of signing the informed consent.
- BMI≥ 35.0 kg/m\^2.
- Participants without T2D: No history of T2D and HbA1c \< 6.5% (48 millimoles per mole (mmol/mol)) Participants with T2D: A history of T2D and HbA1c...
You likely can't join if
- A self-reported change in body weight \> 5% within 90 days before screening, irrespective of medical records.
- Use of any glucagon-like-peptide-1 receptor agonist (GLP-1 RA), including medication with GLP-1 RA activity, or amylin analogues, including...
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- Pelham, Alabama, United States
- Gilbert, Arizona, United States
- Phoenix, Arizona, United States
- Little Rock, Arkansas, United States
- Escondido, California, United States
- La Mesa, California, United States
- Lincoln, California, United States
- Loma Linda, California, United States
- Los Alamitos, California, United States
- Northridge, California, United States
- Palm Springs, California, United States
- San Diego, California, United States
- Van Nuys, California, United States
- Walnut Creek, California, United States
- Aurora, Colorado, United States
- Clearwater, Florida, United States
- Fleming Island, Florida, United States
- Jacksonville, Florida, United States
- Miami, Florida, United States
+ 217 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 83 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; Pelham, Alabama, United States; Gilbert, Arizona, United States; Phoenix, Arizona, United States; Little Rock, Arkansas, United States; Escondido, California, United States and 231 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.